Related Experiment Video
Updated: Sep 14, 2026

Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
Published on: April 6, 2014
In situ transformable fibrillar networks ameliorate secondary brain injury after intracerebral hemorrhage by
Yipin Liu1, Wenyuan Zhang2, Jingwen Wang1
1Department of Neurosurgery, The Second People's Hospital of Longgang District, Shenzhen, 518112, China; Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, China; Shenzhen Clinical Medical College, Guangzhou University of Chinese Medicine, Shenzhen, 518000, China.
Abstract:
Intracerebral hemorrhage (ICH) is among the most severe stroke subtypes, especially the secondary brain injury synergistically driven by oxidative stress and neuroinflammation, which leads to severe progressive tissue damage and neurological deterioration. Currently, there are no effective and long-lasting targeted treatments for secondary brain injury caused by ICH. Here, we report an in situ biomimetic self-assembly strategy based on a fibrillar, transformable peptide (NKF) that coordinately suppresses oxidative stress and neuroinflammation. In aqueous solution, NKF self-assembles into nanoparticles; upon binding to KEAP1 in microglia, however, it undergoes an in situ transformation into nanofibrils, thereby enhancing intracellular retention and sustaining KEAP1 sequestration. In cellular and rat ICH models, NKF promotes sustained Nrf2 nuclear translocation and ARE-dependent transcription, resulting in enhanced antioxidant defense, attenuated pro-inflammatory signaling, and a shift in microglial phenotype towards a neuroprotective anti-inflammatory state. This physical conformation transformation strategy based on lesion-responsive peptide biomimetic assembly establishes a generalizable nanoplatform for durable activation of an endogenous neuroprotective pathway.
Related Concept Videos
Secondary Spinal Cord Injury llI: Pathophysiology
Hemorrhagic Stroke ll: Pathophysiology